Alzamend Neuro, Inc. financial data

Symbol
ALZN on Nasdaq
Location
Atlanta, GA
Fiscal year end
30 April
Latest financial report
10-Q - Q3 2025 - 09 Dec 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 18% %
Return On Equity -181% % -144%
Return On Assets -116% % 60%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3,801,604 shares -30%
Common Stock, Shares, Outstanding 3,801,604 shares -27%
Entity Public Float $8,200,000 USD 22%
Common Stock, Value, Issued $380 USD -27%
Weighted Average Number of Shares Outstanding, Basic 3,380,968 shares 762%
Weighted Average Number of Shares Outstanding, Diluted 3,380,968 shares 762%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $2,814,419 USD 7.8%
General and Administrative Expense $3,060,242 USD -5%
Operating Income (Loss) $5,874,661 USD -0.76%
Nonoperating Income (Expense) $7,660 USD 61%
Net Income (Loss) Attributable to Parent $5,882,321 USD -0.55%
Earnings Per Share, Basic 2.13 USD/shares 92%
Earnings Per Share, Diluted 2.13 USD/shares 92%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,449,433 USD 8.7%
Assets, Current $4,721,448 USD -0.95%
Property, Plant and Equipment, Net $370,236 USD 54%
Assets $5,091,684 USD 1.7%
Accounts Payable, Current $725,851 USD -81%
Liabilities $717,488 USD -43%
Retained Earnings (Accumulated Deficit) $62,238,703 USD -10%
Stockholders' Equity Attributable to Parent $4,374,196 USD 17%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3,968,222 USD
Liabilities and Equity $5,091,684 USD 1.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,362,786 USD -124%
Net Cash Provided by (Used in) Financing Activities $4,035,000 USD 105%
Net Cash Provided by (Used in) Investing Activities $90,000 USD 39%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 3,801,604 shares -27%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,449,433 USD 8.7%
Deferred Tax Assets, Valuation Allowance $15,247,397 USD -3.3%
Deferred Tax Assets, Gross $15,271,245 USD -3.3%
Depreciation $27,685 USD 118%
Deferred Tax Assets, Operating Loss Carryforwards $10,566,664 USD -2.5%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $66,612,519 USD 11%
Share-based Payment Arrangement, Expense $81,277 USD -56%
Interest Expense $7,660 USD -61%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%